Modification of the duocarmycin pharmacophore enables CYP1A1 targeting for biological activity

Klaus Pors, Paul M. Loadman, Steven D. Shnyder, Mark Sutherland, Helen M. Sheldrake, Meritxell Guino, Konstantinos Kiakos, John A. Hartley, Mark Searcey, Laurence H. Patterson
  • Chemical Communications, January 2011, Royal Society of Chemistry
  • DOI: 10.1039/c1cc15638a
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Professor Mark Searcey